iRhythm Holdings, Inc. (IRTC) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2023-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2023-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2023-12-31..
Borrowing debt
Overview →Financial period ending 2023-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2023-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2023-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2023-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 34.95M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 133.76M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 433.14M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | (m) | (m) | (m) | $34.95M | (m) | $133.76M | $433.14M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $34.95M | (m) | $158.47M | $439.77M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $34.94M | (m) | $164.74M | $429.49M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $34.94M | (m) | $176.34M | $421.70M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $34.94M | (m) | $213.14M | $448.22M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $34.93M | (m) | $203.54M | $440.39M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $34.93M | (m) | $204.49M | $435.69M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $34.92M | (m) | $208.78M | $428.72M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $9.69M | (m) | $239.13M | $462.97M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $12.60M | (m) | $256.77M | $480.25M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $15.52M | (m) | $255.66M | $485.22M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $18.43M | (m) | $262.29M | $478.49M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $21.34M | (m) | $335.22M | $511.74M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $24.25M | (m) | $327.24M | $497.20M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $27.16M | (m) | $114.93M | $276.22M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $30.08M | (m) | $121.77M | $282.94M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $32.99M | (m) | $140.55M | $306.21M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $34.93M | (m) | $152.72M | $310.08M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $34.93M | (m) | $59.39M | $207.29M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $34.92M | (m) | $58.74M | $117.18M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $34.90M | (m) | $78.34M | $119.71M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $32.55M | (m) | $81.18M | $118.99M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $32.57M | (m) | $85.92M | $120.92M | (m) |
| 2018-03-31 | (m) | (m) | $1.50M | $32.53M | (m) | $90.74M | $122.32M | (m) |
| 2017-12-31 | (m) | (m) | $1.49M | $32.49M | (m) | $107.94M | $133.12M | (m) |
| 2017-09-30 | (m) | (m) | $1.48M | $32.05M | (m) | $125.86M | $133.66M | (m) |
| 2017-06-30 | (m) | (m) | $1.47M | $31.61M | (m) | $122.89M | $134.38M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $32.65M | (m) | $107.01M | $132.80M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $32.23M | (m) | $151.99M | $138.16M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $31.80M | (m) | (m) | $27.38M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $30.55M | (m) | (m) | $37.87M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |